M
Michael J. Mack
Researcher at Scott & White Hospital
Publications - 634
Citations - 36680
Michael J. Mack is an academic researcher from Scott & White Hospital. The author has contributed to research in topics: Valve replacement & Medicine. The author has an hindex of 89, co-authored 519 publications receiving 28877 citations. Previous affiliations of Michael J. Mack include Baylor University Medical Center & Medical City Dallas Hospital.
Papers
More filters
Journal ArticleDOI
A tale of two trials; chapter 2.
Michael J. Mack,Paul A. Grayburn +1 more
TL;DR: Two randomized trials attempting to determine the benefits (if any) of the correction of moderate to severe or severe secondary (functional) mitral regurgitation with the MitraClip device in patients with heart failure found discordant outcomes.
Journal ArticleDOI
Ventricular Remodeling and Outcomes After Mitral Transcatheter Edge-to-Edge Repair in Heart Failure: The COAPT Trial.
Brian R. Lindman,Federico M. Asch,Paul A. Grayburn,Michael J. Mack,Jeroen J. Bax,Holly Gonzales,Kashish Goel,Colin MacLeod Barker,Sandip Zalawadiya,Maria Alu,Neil J. Weissman,William T. Abraham,JoAnn Lindenfeld,Gregg W. Stone +13 more
TL;DR: In this paper , the authors evaluated the relationship between left ventricular (LV) remodeling and clinical outcomes after treatment of severe mitral regurgitation (MR) in heart failure (HF) has not been examined.
Journal ArticleDOI
The Heart Team: Where did it Come from and Where is it Going
TL;DR: The Heart Team concept arose during a time when Interventional Cardiology and Cardiovascular Surgery were grappling with and exploring competitive revascularization strategies in patient care.
Journal ArticleDOI
Public reporting: A new threat to high‐risk patients and medical innovation
TL;DR: Public reporting of hospital and physician outcomes is part of the continued initiative to improve quality by informing patients and healthcare providers about these outcome data so that informed decisions can be made and has the potential to have significant unintended consequences on patients, society, and the medical community.
Journal ArticleDOI
Health economic outcomes of the SYNTAX trial.
TL;DR: The conclusion of this study should be viewed with caution until the planned 5-year health economic analysis of SYNTAX because based on what the authors already know at 4 years, the health economic profiles of the two procedures are likely to be significantly different from the 12-month results presented here.